Suma Krishnan
CIK 1298711 · President, R&D · last filed 2026-06-05
Suma Krishnan is a President, R&D who has filed 55 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider sold $7.7M of KRYS on Jun 5, 2026. Across all open-market trades the lifetime net is −$125.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $487.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$487.95M
3
55
-$125.35M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KRYS | President, R&D | 1,430,434 | $341.12 | $487.95M | -$124.60M | 37 | 2026-06-05 |
| PRECIGEN, INC. (XON) Delisted | SVP--Product Development | 113,314 | — | — | -$745.4K | 4 | 2016-02-01 |
| NEW RIVER PHARMACEUTICALS INC (NRPH) Delisted | Vice President, Product Dev. | — | — | — | $0 | 1 | 2007-01-31 |
Recent Filings
55 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | KRYS | Sell (S) | −25,000 | -$7.70M | EDGAR |
| 2026-06-04 | KRYS | Notice (144) | −25,000 | -$7.55M | EDGAR |
| 2026-03-06 | KRYS | Sell (S) | −25,000 | -$6.58M | EDGAR |
| 2026-03-04 | KRYS | Notice (144) | −25,000 | -$6.59M | EDGAR |
| 2026-03-03 | KRYS | Mixed | +36,641 | -$8.43M | EDGAR |
| 2025-12-05 | KRYS | Mixed | −55,000 | -$11.01M | EDGAR |
| 2025-12-04 | KRYS | Notice (144) | −25,000 | -$5.44M | EDGAR |
| 2025-07-16 | KRYS | Sell (S) | −35,873 | -$5.40M | EDGAR |
| 2025-07-11 | KRYS | Sell (S) | −14,127 | -$2.12M | EDGAR |
| 2025-07-09 | KRYS | Notice (144) | −25,000 | -$3.58M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.